Setting

Europe Clinical Diagnostics Market 2021-2031 by Test (Lipid Panel, Infectious Disease Testing, Liver Panel, CBC), Product (Instruments, Assay Kits & Reagents, Software & Services), Indication (Cardiovascular, Cancer, Infectious Disease), Patient Gender (Male, Female), Age Group (44 and below, 45-64, 65 and over), End User, and Country: Trend Forecast and Growth Opportunity

Published: 28 Feb 2022 | Report Code: 10248398 | Pages: 115

Europe clinical diagnostics market was valued at $16,808.4 million in 2021 and will grow by 7.0% annually over 2021-2031, driven by the rising patient awareness and rising demand for high-quality care amid the COVID-19 pandemic, growing healthcare spend, technological advancement, benefits of clinical diagnostics such as quick test results and easy procedure, increasing prevalence of chronic diseases caused due to sedentary lifestyle such as diabetes, cardiovascular diseases, high blood pressure, lipid disorders, kidney diseases and cancer. Highlighted with 33 tables and 60 figures, this 115-page report “Europe Clinical Diagnostics Market 2021-2031 by Test (Lipid Panel, Infectious Disease Testing, Liver Panel, CBC), Product (Instruments, Assay Kits & Reagents, Software & Services), Indication (Cardiovascular, Cancer, Infectious Disease), Patient Gender (Male, Female), Age Group (44 and below, 45-64, 65 and over), End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe clinical diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe clinical diagnostics market in every aspect of the classification from perspectives of by Test, Product, Indication, Patient Gender, Age Group, End User, and Country. Based on Test, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Lipid Panel • Infectious Disease Testing • Liver Panel • Complete Blood Count (CBC) • Electrolyte Testing • Renal Panel • Other Tests Based on Product, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Instruments • Assay Kits & Reagents • Software & Services By Indication the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Cardiovascular • Cancer • Infectious Disease • Stroke • Chronic Lower Respiratory Diseases • Diabetes • Other Indications By Patient Gender the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Male Patients • Female Patients By Age Group the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Age 44 and below • Age 45-64 • Age 65 and over By End User the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Hospital & Clinics Laboratory • Diagnostic Laboratory • Point-of-Care Testing • Other End Users Geographically, the following national/local markets are fully investigated: • Germany • UK • France • Spain • Italy • Russia • Rest of Europe (further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of key national markets by Test, Product, and Indication, over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: • Abbott Laboratories • Becton, Dickinson and Company • BioMerieux SA • Bio-Rad Laboratories Inc. • Bio-Reference Laboratories • Bioscientia Healthcare • Charles River Laboratories • Danaher Corporation • Hoffmann-La Roche AG • Hologic Inc. • Qiagen NV • Siemens Healthcare • Thermo Fisher Scientific (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table Of Contents:

1 Introduction	7
1.1 Industry Definition and Research Scope	7
1.1.1 Industry Definition	7
1.1.2 Research Scope	8
1.2 Research Methodology	11
1.2.1 Overview of Market Research Methodology	11
1.2.2 Market Assumption	12
1.2.3 Secondary Data	12
1.2.4 Primary Data	12
1.2.5 Data Filtration and Model Design	13
1.2.6 Market Size/Share Estimation	14
1.2.7 Research Limitations	15
1.3 Executive Summary	16
2 Market Overview and Dynamics	19
2.1 Market Size and Forecast	19
2.1.1 Impact of COVID-19 on World Economy	20
2.1.2 Impact of COVID-19 on the Market	22
2.2 Major Growth Drivers	24
2.3 Market Restraints and Challenges	30
2.4 Emerging Opportunities and Market Trends	33
2.5 Porter’s Fiver Forces Analysis	37
3 Segmentation of Europe Market by Test	41
3.1 Market Overview by Test	41
3.2 Lipid Panel	43
3.3 Infectious Disease Testing	44
3.4 Liver Panel	45
3.5 Complete Blood Count (CBC)	46
3.6 Electrolyte Testing	47
3.7 Renal Panel	48
3.8 Other Tests	49
4 Segmentation of Europe Market by Product	50
4.1 Market Overview by Product	50
4.2 Instruments	52
4.3 Assay Kits & Reagents	53
4.4 Software & Services	54
5 Segmentation of Europe Market by Indication	55
5.1 Market Overview by Indication	55
5.2 Cardiovascular	57
5.3 Cancer	58
5.4 Infectious Disease	59
5.5 Stroke	60
5.6 Chronic Lower Respiratory Diseases	61
5.7 Diabetes	62
5.8 Other Indications	63
6 Segmentation of Europe Market by Patient Gender	64
6.1 Market Overview by Patient Gender	64
6.2 Male Patients	66
6.3 Female Patients	67
7 Segmentation of Europe Market by Age Group	68
7.1 Market Overview by Age Group	68
7.2 Age 44 and below	70
7.3 Age 45-64	71
7.4 Age 65 and over	72
8 Segmentation of Europe Market by End User	73
8.1 Market Overview by End User	73
8.2 Hospital & Clinics Laboratory	75
8.3 Diagnostic Laboratory	76
8.4 Point-of-Care Testing	77
8.5 Other End Users	78
9 European Market 2021-2031 by Country	79
9.1 Overview of European Market	79
9.2 Germany	82
9.3 U.K.	85
9.4 France	87
9.5 Spain	89
9.6 Italy	91
9.7 Russia	93
9.8 Rest of European Market	95
10 Competitive Landscape	97
10.1 Overview of Key Vendors	97
10.2 New Product Launch, Partnership, Investment, and M&A	100
10.3 Company Profiles	101
Abbott Laboratories	101
Becton, Dickinson and Company	103
BioMerieux SA	104
Bio-Rad Laboratories Inc.	105
Bio-Reference Laboratories	106
Bioscientia Healthcare	107
Charles River Laboratories	108
Danaher Corporation	109
Hoffmann-La Roche AG	110
Hologic Inc.	111
Qiagen NV	112
Siemens Healthcare	113
Thermo Fisher Scientific	114
RELATED REPORTS	115
List Of Tables:


Table 1.  Snapshot of Europe Clinical Diagnostics Market in Balanced Perspective, 2021-2031	17
Table 2. World Economic Outlook, 2021-2031	21
Table 3. World Health Spending by Region, $ bn, 2013-2020	29
Table 4.  Main Product Trends and Market Opportunities in Europe Clinical Diagnostics Market	33
Table 5. Europe Clinical Diagnostics Market by Test, 2021-2031, $ mn	41
Table 6. Europe Clinical Diagnostics Market by Product, 2021-2031, $ mn	50
Table 7. Europe Clinical Diagnostics Market by Indication, 2021-2031, $ mn	55
Table 8. Europe Clinical Diagnostics Market by Patient Gender, 2021-2031, $ mn	64
Table 9. Europe Clinical Diagnostics Market by Age Group, 2021-2031, $ mn	68
Table 10. Europe Clinical Diagnostics Market by End User, 2021-2031, $ mn	73
Table 11. Europe Clinical Diagnostics Market by Country, 2021-2031, $ mn	81
Table 12. Germany Clinical Diagnostics Market by Test, 2021-2031, $ mn	83
Table 13. Germany Clinical Diagnostics Market by Product, 2021-2031, $ mn	83
Table 14. Germany Clinical Diagnostics Market by Indication, 2021-2031, $ mn	83
Table 15. U.K. Clinical Diagnostics Market by Test, 2021-2031, $ mn	86
Table 16. U.K. Clinical Diagnostics Market by Product, 2021-2031, $ mn	86
Table 17. U.K. Clinical Diagnostics Market by Indication, 2021-2031, $ mn	86
Table 18. France Clinical Diagnostics Market by Test, 2021-2031, $ mn	88
Table 19. France Clinical Diagnostics Market by Product, 2021-2031, $ mn	88
Table 20. France Clinical Diagnostics Market by Indication, 2021-2031, $ mn	88
Table 21. Spain Clinical Diagnostics Market by Test, 2021-2031, $ mn	90
Table 22. Spain Clinical Diagnostics Market by Product, 2021-2031, $ mn	90
Table 23. Spain Clinical Diagnostics Market by Indication, 2021-2031, $ mn	90
Table 24. Italy Clinical Diagnostics Market by Test, 2021-2031, $ mn	92
Table 25. Italy Clinical Diagnostics Market by Product, 2021-2031, $ mn	92
Table 26. Italy Clinical Diagnostics Market by Indication, 2021-2031, $ mn	92
Table 27. Russia Clinical Diagnostics Market by Test, 2021-2031, $ mn	94
Table 28. Russia Clinical Diagnostics Market by Product, 2021-2031, $ mn	94
Table 29. Russia Clinical Diagnostics Market by Indication, 2021-2031, $ mn	94
Table 30. Clinical Diagnostics Market in Rest of Europe by Country, 2021-2031, $ mn	96
Table 31. Abbott Laboratories: Company Snapshot	101
Table 32. Abbott Laboratories: Business Segmentation	102
Table 33. Abbott Laboratories: Product Portfolio	102
List Of Figures:


Figure 1. Research Method Flow Chart	11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation	14
Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031	16
Figure 4. Europe Clinical Diagnostics Market, 2021-2031, $ mn	19
Figure 5. Impact of COVID-19 on Business	22
Figure 6. Primary Drivers and Impact Factors of Europe Clinical Diagnostics Market	24
Figure 7.  Leading Causes of Death in the World, 2019-2020, million	27
Figure 8.  Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million	28
Figure 9. World Population 65 and Over, % of Total Population, 1950-2060	28
Figure 10. Primary Restraints and Impact Factors of Europe Clinical Diagnostics Market	30
Figure 11. Investment Opportunity Analysis	34
Figure 12. Porter’s Fiver Forces Analysis of Europe Clinical Diagnostics Market	37
Figure 13. Breakdown of Europe Clinical Diagnostics Market by Test, 2021-2031, % of Revenue	42
Figure 14. Europe Addressable Market Cap in 2022-2031 by Test, Value ($ mn) and Share (%)	42
Figure 15. Europe Clinical Diagnostics Market by Test: Lipid Panel, 2021-2031, $ mn	43
Figure 16. Europe Clinical Diagnostics Market by Test: Infectious Disease Testing, 2021-2031, $ mn	44
Figure 17. Europe Clinical Diagnostics Market by Test: Liver Panel, 2021-2031, $ mn	45
Figure 18. Europe Clinical Diagnostics Market by Test: Complete Blood Count (CBC), 2021-2031, $ mn	46
Figure 19. Europe Clinical Diagnostics Market by Test: Electrolyte Testing, 2021-2031, $ mn	47
Figure 20. Europe Clinical Diagnostics Market by Test: Renal Panel, 2021-2031, $ mn	48
Figure 21. Europe Clinical Diagnostics Market by Test: Other Tests, 2021-2031, $ mn	49
Figure 22. Breakdown of Europe Clinical Diagnostics Market by Product, 2021-2031, % of Sales Revenue	51
Figure 23. Europe Addressable Market Cap in 2022-2031 by Product, Value ($ mn) and Share (%)	51
Figure 24. Europe Clinical Diagnostics Market by Product: Instruments, 2021-2031, $ mn	52
Figure 25. Europe Clinical Diagnostics Market by Product: Assay Kits & Reagents, 2021-2031, $ mn	53
Figure 26. Europe Clinical Diagnostics Market by Product: Software & Services, 2021-2031, $ mn	54
Figure 27. Breakdown of Europe Clinical Diagnostics Market by Indication, 2021-2031, % of Sales Revenue	56
Figure 28. Europe Addressable Market Cap in 2022-2031 by Indication, Value ($ mn) and Share (%)	56
Figure 29. Europe Clinical Diagnostics Market by Indication: Cardiovascular, 2021-2031, $ mn	57
Figure 30. Europe Clinical Diagnostics Market by Indication: Cancer, 2021-2031, $ mn	58
Figure 31. Europe Clinical Diagnostics Market by Indication: Infectious Disease, 2021-2031, $ mn	59
Figure 32. Europe Clinical Diagnostics Market by Indication: Stroke, 2021-2031, $ mn	60
Figure 33. Europe Clinical Diagnostics Market by Indication: Chronic Lower Respiratory Diseases, 2021-2031, $ mn	61
Figure 34. Europe Clinical Diagnostics Market by Indication: Diabetes, 2021-2031, $ mn	62
Figure 35. Europe Clinical Diagnostics Market by Indication: Other Indications, 2021-2031, $ mn	63
Figure 36. Breakdown of Europe Clinical Diagnostics Market by Patient Gender, 2021-2031, % of Revenue	65
Figure 37. Europe Addressable Market Cap in 2022-2031 by Patient Gender, Value ($ mn) and Share (%)	65
Figure 38. Europe Clinical Diagnostics Market by Patient Gender: Male Patients, 2021-2031, $ mn	66
Figure 39. Europe Clinical Diagnostics Market by Patient Gender: Female Patients, 2021-2031, $ mn	67
Figure 40. Breakdown of Europe Clinical Diagnostics Market by Age Group, 2021-2031, % of Revenue	69
Figure 41. Europe Addressable Market Cap in 2022-2031 by Age Group, Value ($ mn) and Share (%)	69
Figure 42. Europe Clinical Diagnostics Market by Age Group: Age 44 and below, 2021-2031, $ mn	70
Figure 43. Europe Clinical Diagnostics Market by Age Group: Age 45-64, 2021-2031, $ mn	71
Figure 44. Europe Clinical Diagnostics Market by Age Group: Age 65 and over, 2021-2031, $ mn	72
Figure 45. Breakdown of Europe Clinical Diagnostics Market by End User, 2021-2031, % of Revenue	73
Figure 46. Europe Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%)	74
Figure 47. Europe Clinical Diagnostics Market by End User: Hospital & Clinics Laboratory, 2021-2031, $ mn	75
Figure 48. Europe Clinical Diagnostics Market by End User: Diagnostic Laboratory, 2021-2031, $ mn	76
Figure 49. Europe Clinical Diagnostics Market by End User: Point-of-Care Testing, 2021-2031, $ mn	77
Figure 50. Europe Clinical Diagnostics Market by End User: Other End Users, 2021-2031, $ mn	78
Figure 51. Breakdown of European Clinical Diagnostics Market by Country, 2021 and 2031, % of Revenue	80
Figure 52. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)	81
Figure 53.  Clinical Diagnostics Market in Germany, 2021-2031, $ mn	82
Figure 54.  Clinical Diagnostics Market in U.K., 2021-2031, $ mn	85
Figure 55.  Clinical Diagnostics Market in France, 2021-2031, $ mn	87
Figure 56.  Clinical Diagnostics Market in Spain, 2021-2031, $ mn	89
Figure 57.  Clinical Diagnostics Market in Italy, 2021-2031, $ mn	91
Figure 58.  Clinical Diagnostics Market in Russia, 2021-2031, $ mn	93
Figure 59.  Clinical Diagnostics Market in Rest of Europe, 2021-2031, $ mn	95
Figure 60. Growth Stage of Europe Clinical Diagnostics Industry over the Forecast Period	97
Selected Key Players: 
•	Abbott Laboratories
•	Becton, Dickinson and Company
•	BioMerieux SA
•	Bio-Rad Laboratories Inc.
•	Bio-Reference Laboratories
•	Bioscientia Healthcare
•	Charles River Laboratories
•	Danaher Corporation
•	Hoffmann-La Roche AG
•	Hologic Inc.
•	Qiagen NV
•	Siemens Healthcare
•	Thermo Fisher Scientific 
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)